July 10, 2007 (Framingham, MA) - A new analysis of the Framingham Offspring Cohort has found that individuals with reduced estimated glomerular filtration rate (eGFR) and microalbuminuria are at ...

Levels of kidney function alone had no apparent impact on the risk for diabetic ketoacidosis (DKA) among adults with type 1 diabetes (T1D), regardless of the use of kidney protective medication, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients on canagliflozin had a 30.8% decrease in ...

Please provide your email address to receive an email when new articles are posted on . Rapid eGFR decline occurred in 23% of patients on high-intensity exercise. Meanwhile, rapid eGFR decline ...

The use of semaglutide for non-diabetic obese patients with cardiovascular disease was first reported to be associated with significant benefit in the SELECT trial, where major adverse cardiovascular ...

Credit: Shutterstock Accurate assessment of glomerular filtration rate in patients with cancer is crucial to determine drug eligibility and dosing, while balancing the risks for undertreatment and ...

Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease ...

Uncommon EGFR mutations in NSCLC, such as exon 20 insertions, are being targeted by new therapies like amivantamab, zipalertinib, and furmonertinib. Subcutaneous amivantamab, combined with lazertinib, ...

SAN DIEGO -- Finerenone (Kerendia) yielded minimal renal benefit in patients with heart failure with mildly reduced or preserved ejection fraction, according to a secondary analysis of the FINEARTS-HF ...

CStone Pharmaceuticals ( (HK:2616)) has shared an update. CStone Pharmaceuticals has initiated global clinical development of CS5007, an EGFR/HER3 bispecific antibody-drug conjugate, after receiving ...